EDWARDS LIFESCIENCES, LLC for EDWARDS LIFESCIENCES LLC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Federal Corporate Tax Rate H.R 160, Protect Medical Innovation Act of 2015 Repatriation S. 149, Medical Device Access & Innovation Protection Act Tax Reform International Tax Issues Treasury Anti-inversion Regulation Section 385
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH RAYE KEGLER | — |
| BARRY ROBERT LIDEN | — |
Health Issues HCR
H.R. 160, Protect Medical Innovation Act of 2015 H.R. 6, 21st Century Cures Act S. 149, Medical Device Access & Innovation Protection Act Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveillance FDA Quality Problems
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH RAYE KEGLER | — |
| BARRY ROBERT LIDEN | — |
Medicare/Medicaid MMM
CMS Coverage Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016 S. 2998, Ensuring Patient Access to Critical Breakthrough Products Act of 2016
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH RAYE KEGLER | — |
| BARRY ROBERT LIDEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.